Biography
Balaji V. Kadri, is currently Director of Formulation Development & Clinical Manufacturing at QS Pharma, LLC. Mr. Kadri has more than 18 years of formulation and process development experience within the contract research and generic industry. He was previously senior director of Pharmaceutical Operations at PharmaForm, where he was responsible for analytical, formulation development, and cGMP manufacturing. Prior to that, he headed the Preformulation and Formulation Development group at Xcelience, LLC for 10 years. He previously worked in formulation development and scale-up manufacturing at Apotex for six years. His broad dosage form experience includes immediate release tablets and capsules, sustained release capsules/tablets/beads, liquid/semi-solid in capsule, gels, paediatric solutions, suspensions, and parenteral. His expertise includes formulation development from preclinical to commercialization, overcoming solubilization challenges, enhancing bioavailability, taste masking, and development of controlled release dosage forms. He has authored numerous articles, presented many abstracts, is co-inventor of several patents and is a contributor of several excipient monographs in “Handbook of Pharmaceutical Excipients†7th edition (2012). He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and a registered life member in the Karnataka State Pharmacy Council in India.
Research Interest
Formulation development
Biography
Dr. Bootman has served as Dean of The University of Arizona College of Pharmacy since 1987. He is professor of pharmacy, medicine and public health, and a Fellow of several professional associations including the American Pharmacists Association, American Association of Pharmaceutical Scientists and the American College of Apothecaries. He is the Founding and Executive Director of the University of Arizona Center for Health Outcomes and PharmacoEconomic Research, one of the first such centers developed in the world. He received his pharmacy education at The University of Arizona and his doctorate at The University of Minnesota. In 2008 he was recognized with the Joseph P. Remington Honor Medal, the highest honor given by the profession of pharmacy to recognize distinguished service and lifetime contributions.
Research Interest
Pharmaceutics and Novel Drug Delivery
Biography
Professor Al-Ghananeem is the Associate Dean of Research and Graduate Program at Sullivan University College of Pharmacy, Kentucky, USA. She has completed her Ph.D. in Pharmaceutical Sciences from University of Kentucky, USA. Dr. Al-Ghananeem is an author of over 60 peer-reviewed research articles, symposium abstracts, and patent applications. She serves on the Editorial Advisory Board for many reputable pharmaceutical and clinical journals. Her research focuses on developing innovative formulation technologies for transmucosal, oral, and parenteral drug delivery. Her interests also include process development of various dosage forms and formulations for industrial technology transfer.
Research Interest
Developing innovative technologies for transmucosal, oral, and parenteral drug delivery and development of various dosage forms and formulations for industrial technology transfer.